z-logo
open-access-imgOpen Access
Vitamin D receptor FokI, BsmI, ApaI, and TaqI polymorphisms and the susceptibility to breast cancer: a meta-analysis
Author(s) -
Young Ho Lee,
Gwan Gyu Song
Publication year - 2014
Publication title -
neoplasma
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.628
H-Index - 50
eISSN - 1338-4317
pISSN - 0028-2685
DOI - 10.4149/neo_2014_077
Subject(s) - foki , taqi , calcitriol receptor , breast cancer , meta analysis , medicine , genotype , allele , oncology , vitamin d and neurology , incidence (geometry) , gastroenterology , endocrinology , polymorphism (computer science) , biology , cancer , genetics , physics , gene , optics
The goal of this study is to examine whether vitamin D receptor (VDR) polymorphisms are associated with the susceptibility to breast cancer. Meta-analysis was employed to investigate the association between the VDR FokI, BsmI, ApaI, and TaqI polymorphisms and the incidence of breast cancer.A total of 32 comparative studies were evaluated in this meta-analysis, which included 17,067 patients and 20,843 controls. Meta-analysis of the VDR FokI polymorphism indicated an association between the incidence of breast cancer and the ff genotype in Europeans (OR = 1.126, 95% CI = 1.026-1.243, p = 0.019). Furthermore, an association between the incidence of breast cancer and the VDR FokI polymorphism was found in the Europeans using the allele contrast, as well as the homozygote contrast. However, the meta-analysis indicated no association between breast cancer and the BsmI polymorphism in all study subjects, including the Europeans (OR for the B allele = 0.996, 95% CI = 0.964-1.097, p = 0.930, 1.026, 95% CI = 0.929-1.134, p = 0.610). Moreover, breast cancer incidence was not associated with the ApaI and Taq polymorphisms (OR for the A allele = 0.908, 95% CI = 0.763-1.041, p = 0.167, OR for the T allele = 0.972, 95% CI = 0.929-1.017, p = 0.221).This meta-analysis suggests that the VDR FokI polymorphism is associated with susceptibility to breast cancer in the European population.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here